ARWR 241220 30.00P (ARWR241220P30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ARWR241220P30000

Watchlist

8.90
-2.60-22.61%

15min DelayClose Nov 26 16:00 ET

8.90High8.80Low

Intraday

5D
Daily

News

Arrowhead Pharma +17% After Signing Deal with Sarepta Therapeutics
MT Newswires11:23 ET
Arrowhead Pharmaceuticals Inc (ARWR) Q4 2024 Earnings Call Highlights: Transformational ...
Yahoo Finance17minutes ago
TD Cowen Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
Moomoo News23:31 ET · Ratings
Arrowhead Pharmaceuticals Eyes Future Growth With Strategic Deals
TipRanks22:56 ET
Arrowhead Pharmaceuticals | 10-K: Annual report
SEC22:32 ET · Announcements
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga16:06 ET

Comments

Andrew Whiteside

Nov 22 09:29

$Arrowhead Pharmaceuticals (ARWR.US)$ $50

stockhub

Apr 7 11:23

Hope price action is consistent with result

Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertriglyceridemia
$Arrowhead Pharmaceuticals (ARWR.US)$

Mooers' Insights

Tonyco

Apr 6 22:01

$Arrowhead Pharmaceuticals (ARWR.US)$
Insiderd selling shares and financials dont look good. Im guessing they dont have anything in the pipeline?

Moomoo AI

Mar 8 05:54

The company's poor performance and the CEO's high pay, despite falling earnings and shareholder value, may upset shareholders. The upcoming AGM on March 14th is a chance for shareholders to hold the board and management accountable.

We Think Shareholders May Want To Consider A Review Of Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) CEO Compensation Package

zulia3003

Mar 7 11:34

$Arrowhead Pharmaceuticals (ARWR.US)$ why drop today?